SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 50 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,038,479 | -30.1% | 555,336 | -6.2% | 0.00% | – |
| Q2 2023 | $1,485,884 | +10.3% | 591,986 | -23.1% | 0.00% | – |
| Q1 2023 | $1,347,098 | +44.8% | 769,771 | +251.6% | 0.00% | – |
| Q4 2022 | $930,482 | +122.6% | 218,937 | -37.7% | 0.00% | – |
| Q3 2022 | $418,000 | +100.0% | 351,337 | +67.9% | 0.00% | – |
| Q2 2022 | $209,000 | -74.0% | 209,193 | -36.1% | 0.00% | – |
| Q1 2022 | $803,000 | -16.6% | 327,579 | -8.5% | 0.00% | – |
| Q4 2021 | $963,000 | -30.8% | 358,184 | +28.9% | 0.00% | – |
| Q3 2021 | $1,392,000 | -14.2% | 277,946 | +27.8% | 0.00% | – |
| Q2 2021 | $1,623,000 | +28.5% | 217,537 | +1.1% | 0.00% | – |
| Q1 2021 | $1,263,000 | +5.8% | 215,184 | -15.3% | 0.00% | – |
| Q4 2020 | $1,194,000 | +65.1% | 254,107 | +21.0% | 0.00% | – |
| Q3 2020 | $723,000 | – | 210,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 6,304,705 | $15,824,810 | 0.09% |
| Virtus ETF Advisers LLC | 55,763 | $139,965 | 0.08% |
| VANCE WEALTH, INC. | 39,266 | $98,558 | 0.04% |
| CSS LLC/IL | 266,514 | $668,950 | 0.04% |
| SHELL ASSET MANAGEMENT CO | 322,738 | $810 | 0.03% |
| Steward Partners Investment Advisory, LLC | 600,000 | $1,506,000 | 0.02% |
| Alpine Global Management, LLC | 30,000 | $75,300 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 50,000 | $125,500 | 0.02% |
| BENDER ROBERT & ASSOCIATES | 24,059 | $60,388 | 0.02% |
| HoyleCohen, LLC | 74,408 | $186,765 | 0.02% |